Evidence map›Paper›PMID 37919231›Full record

ArticleThe journal of pathology. Clinical research2024

Engineering the future of 3D pathology.

Jonathan Tc Liu, Sarah Sl Chow, Richard Colling, Michelle R Downes, Xavier Farré, Peter Humphrey, Andrew Janowczyk, Tuomas Mirtti, Clare Verrill, Inti Zlobec and 1 more

Abstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Assessing the Effects of a 3-Dimensional (3D) Pathology Tissue-Processing Workflow on Downstream Molecular Analyses.Laboratory investigation; a journal of technical methods and pathology · 2026
    Article
  3. Prototype-based AI triage for 3D pathology.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. PanIN or IPMN? Redefining Lesion Size in 3 Dimensions.The American journal of surgical pathology · 2024
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonathan Tc LiuDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.ORCID 0000-0001-5650-3086
Sarah Sl ChowDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.ORCID 0009-0005-7519-9346
Richard CollingJohn Radcliffe Hospital, University of Oxford, Oxford, UK.
Michelle R DownesSunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Xavier FarréPublic Health Agency of Catalonia, Lleida, Spain.ORCID 0000-0001-8702-4643
Peter HumphreyDepartment of Urology, Yale School of Medicine, New Haven, CT, USA.
Andrew JanowczykWallace H Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, USA.
Tuomas MirttiHelsinki University Hospital and University of Helsinki, Helsinki, Finland.
Clare VerrillJohn Radcliffe Hospital, University of Oxford, Oxford, UK.ORCID 0000-0002-4905-8233
Inti ZlobecInstitute for Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
Lawrence D TrueDepartment of Laboratory Medicine & Pathology, University of Washington School of Medicine, Seattle, USA.

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
KPMP Kidney Mapping and Atlas Project (KMAP)U01DK133090 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$10.4M
Computational Pathology of Proteinuric DiseasesR01DK118431 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BARISONI, LAURA MARIACHIARA, HODGIN, JEFFREY BENTON · 2018 to 2025
$3.6M
Prostate cancer risk stratification via computational 3D pathologyR01CA268207 · NCI · UNIVERSITY OF WASHINGTON · PI Jonathan T.C. Liu, Anant Madabhushi · 2022 to 2026
$3.1M
Instrumentation platform for 3D pathology with open-top light-sheet microscopyR01EB031002 · NIBIB · UNIVERSITY OF WASHINGTON · PI LIU, JONATHAN T.C. · 2021 to 2024
$1.9M
Histotools: scaling digital pathology curation tools for quality control, annotation, labeling, and dataset identificationR01LM013864 · NLM · EMORY UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT · 2022 to 2025
$1.4M
RadxTools for assessing tumor treatment response on imagingU01CA248226 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TIWARI, PALLAVI, VISWANATH, SATISH EASWAR · 2020 to 2022
$1.4M
HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0M
NCI NIH HHS P50 CA097186NCI NIH HHS R01 CA268207NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NIBIB NIH HHS R01 EB031002NIBIB NIH HHS R01EB031002NIDDK NIH HHS R01 DK118431NIDDK NIH HHS U01 DK133090NLM NIH HHS R01 LM013864Prostate Cancer UK
6 · The paper itself

Abstract

In recent years, technological advances in tissue preparation, high-throughput volumetric microscopy, and computational infrastructure have enabled rapid developments in nondestructive 3D pathology, in which high-resolution histologic datasets are obtained from thick tissue specimens, such as whole biopsies, without the need for physical sectioning onto glass slides. While 3D pathology generates massive datasets that are attractive for automated computational analysis, there is also a desire to use 3D pathology to improve the visual assessment of tissue histology. In this perspective, we discuss and provide examples of potential advantages of 3D pathology for the visual assessment of clinical specimens and the challenges of dealing with large 3D datasets (of individual or multiple specimens) that pathologists have not been trained to interpret. We discuss the need for artificial intelligence triaging algorithms and explainable analysis methods to assist pathologists or other domain experts in the interpretation of these novel, often complex, large datasets.

Indexed as

Artificial IntelligenceMicroscopyBiopsyHumansdigital pathologylight-sheet microscopynondestructive 3D pathologyprognosisprostate cancer

Identifiers

PMID37919231
PMCPMC10807588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.